Meeting the challenge of Antimicrobial Resistance (AMR)

05/10/23 • 36 min

Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society.

PP-UNP-GBR-11741 / March 2025

PP-UNP-GBR-11741 / March 2025

Previous Episode

What can we learn from COVID-19 to address other healthcare challenges?

Join Dr Ellie Cannon as she talks to Susan Rienow, Country President at Pfizer UK (at time of recording) and Dr Richard Torbett, CEO of the Association of the British Pharmaceutical Industry, about the lessons learnt from the COVID-19 pandemic and how this could be applied to address other major healthcare challenges.

PP-UNP-GBR-10858 / November 2024

Next Episode

Delivering a step forward for rare disease patients

Dr Ellie Cannon is joined by Dr. Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK, to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.

PP-UNP-GBR-6142 / August 2023